These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36263629)

  • 1. Intestinal histomorphological and molecular alterations in patients with Parkinson's disease.
    Bellini G; Benvenuti L; Ippolito C; Frosini D; Segnani C; Rettura F; Pancetti A; Bertani L; D'Antongiovanni V; Palermo G; Del Prete E; Antonioli L; Nardini V; Morganti R; Pellegrini C; Bernardini N; Ceravolo R; Fornai M; Bellini M
    Eur J Neurol; 2023 Nov; 30(11):3440-3450. PubMed ID: 36263629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
    Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
    Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease.
    Pellegrini C; D'Antongiovanni V; Ippolito C; Segnani C; Antonioli L; Fornai M; Bernardini N
    Eur J Histochem; 2021 Nov; 65(s1):. PubMed ID: 34802221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Ippolito C; Segnani C; Dolfi A; Errede M; Virgintino D; Fornai M; Antonioli L; Garelli F; Nericcio A; Colucci R; Cerri S; Blandini F; Blandizzi C; Bernardini N
    Neurobiol Dis; 2020 Jun; 139():104821. PubMed ID: 32088380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
    Pellegrini C; D'Antongiovanni V; Miraglia F; Rota L; Benvenuti L; Di Salvo C; Testa G; Capsoni S; Carta G; Antonioli L; Cattaneo A; Blandizzi C; Colla E; Fornai M
    NPJ Parkinsons Dis; 2022 Jan; 8(1):9. PubMed ID: 35022395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease.
    Shi J; Wang Y; Chen D; Xu X; Li W; Li K; He J; Su W; Luo Q
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1917-1929. PubMed ID: 36795141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
    Pellegrini C; Antonioli L; Colucci R; Blandizzi C; Fornai M
    Acta Neuropathol; 2018 Sep; 136(3):345-361. PubMed ID: 29797112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic inflammation in Parkinson's disease.
    Devos D; Lebouvier T; Lardeux B; Biraud M; Rouaud T; Pouclet H; Coron E; Bruley des Varannes S; Naveilhan P; Nguyen JM; Neunlist M; Derkinderen P
    Neurobiol Dis; 2013 Feb; 50():42-8. PubMed ID: 23017648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-directed therapy in Parkinson's disease.
    Benvenuti L; Di Salvo C; Bellini G; Seguella L; Rettura F; Esposito G; Antonioli L; Ceravolo R; Bernardini N; Pellegrini C; Fornai M
    Front Pharmacol; 2024; 15():1407925. PubMed ID: 38974034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease.
    Benvenuti L; D'Antongiovanni V; Pellegrini C; Antonioli L; Bernardini N; Blandizzi C; Fornai M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric glial cell reactivity in colonic layers and mucosal modulation in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.
    Thomasi BBM; Valdetaro L; Ricciardi MCG; Hayashide L; Fernandes ACMN; Mussauer A; da Silva ML; da Cunha Faria-Melibeu A; Ribeiro MGL; de Mattos Coelho-Aguiar J; Campello-Costa P; Moura-Neto V; Tavares-Gomes AL
    Brain Res Bull; 2022 Sep; 187():111-121. PubMed ID: 35772606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
    Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
    Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Nardostachys jatamansi on gut microbiota of rats with Parkinson's disease].
    Wan GH; Wei XJ; Li JY; Yang X; Yu JH; Liu JF; Wang YQ; Lyu Y; Jin ZX; Shi JL
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):499-510. PubMed ID: 35178995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.